Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for Ani Pharmaceuticals (ANIP) over the last 14 years, with Dec 2024 value amounting to 0.00%.

  • Ani Pharmaceuticals' Return on Capital Employed rose 5.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 5.00%. This contributed to the annual value of 0.00% for FY2024, which is 7.00% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Return on Capital Employed is 0.00%, which was down 99.05% from 0.07% recorded in FY2023.
  • Ani Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.07% for FY2023, and its period low was -0.08% during FY2021.
  • For the 3-year period, Ani Pharmaceuticals' Return on Capital Employed averaged around 0.01%, with its median value being 0.00% (2024).
  • As far as peak fluctuations go, Ani Pharmaceuticals' Return on Capital Employed decreased by 8bps in 2020, and later climbed by 12bps in 2023.
  • Ani Pharmaceuticals' Return on Capital Employed (Yearly) stood at -0.04% in 2020, then decreased by 3bps to -0.08% in 2021, then climbed by 2bps to -0.05% in 2022, then grew by 12bps to 0.07% in 2023, then decreased by 7bps to 0.00% in 2024.